Symbols / CMRA $0.00 +0.00% Comera Life Sciences Holdings, Inc.

Healthcare • Biotechnology • United States • PNK
CMRA Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Fundamentals
Scroll to Statements
Market Cap 3.07K Enterprise Value 3.12M Income -9.35M Sales 1.00M Book/sh -0.14 Cash/sh 0.06
Dividend Yield — Payout 0.00% Employees 12 IPO — P/E — Forward P/E —
PEG — P/S 0.00 P/B -0.00 P/C — EV/EBITDA -0.41 EV/Sales 3.12
Quick Ratio 0.64 Current Ratio 0.90 Debt/Eq 549.04 LT Debt/Eq — EPS (ttm) -0.22 EPS next Y —
EPS Growth — Revenue Growth -42.00% Earnings — ROA -119.35% ROE -16.29% ROIC —
Gross Margin 73.52% Oper. Margin -15.82% Profit Margin 0.00% Shs Outstand 30.74M Shs Float 13.53M Short Float 1.36%
Short Ratio 0.84 Short Interest — 52W High 0.00 52W Low 0.00 Beta -72.41 Avg Volume 97.00
Volume 730.00 Target Price — Recom None Prev Close $0.00 Price $0.00 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-1.75
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2022-12-31 2021-12-31
Total Revenue
0.63
+97.95%
0.32
Operating Revenue
0.63
+97.95%
0.32
Cost Of Revenue
0.21
+30.67%
0.16
Reconciled Cost Of Revenue
0.21
+30.67%
0.16
Gross Profit
0.42
+166.15%
0.16
Operating Expense
12.39
+117.63%
5.69
Research And Development
1.74
-0.73%
1.75
Selling General And Administration
10.65
+170.26%
3.94
General And Administrative Expense
10.65
+170.26%
3.94
Other Gand A
10.65
+170.26%
3.94
Total Expenses
12.60
+115.24%
5.86
Operating Income
-11.97
-116.24%
-5.54
Total Operating Income As Reported
-11.97
-116.24%
-5.54
EBITDA
-17.89
-233.41%
-5.37
Normalized EBITDA
-13.33
-141.25%
-5.53
Reconciled Depreciation
0.09
+9.07%
0.09
EBIT
-17.98
-229.87%
-5.45
Total Unusual Items
-4.56
-2938.29%
0.16
Total Unusual Items Excluding Goodwill
-4.56
-2938.29%
0.16
Special Income Charges
-6.57
-4189.24%
0.16
Other Special Charges
—
-0.16
Restructuring And Mergern Acquisition
6.57
0.00
Net Income
-18.00
-230.24%
-5.45
Pretax Income
-18.00
-230.24%
-5.45
Net Non Operating Interest Income Expense
-0.02
0.00
Interest Expense Non Operating
0.02
0.00
Net Interest Income
-0.02
0.00
Interest Expense
0.02
0.00
Other Income Expense
-6.01
-7271.96%
0.08
Other Non Operating Income Expenses
-1.46
-1797.03%
-0.08
Gain On Sale Of Security
2.01
—
Tax Rate For Calcs
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
Net Income Including Noncontrolling Interests
-18.00
-230.24%
-5.45
Net Income From Continuing Operation Net Minority Interest
-18.00
-230.24%
-5.45
Net Income From Continuing And Discontinued Operation
-18.00
-230.24%
-5.45
Net Income Continuous Operations
-18.00
-230.24%
-5.45
Normalized Income
-13.45
-139.58%
-5.61
Net Income Common Stockholders
-18.38
-237.10%
-5.45
Otherunder Preferred Stock Dividend
0.37
0.00
Diluted EPS
-1.76
-516.19%
-0.29
Basic EPS
-1.76
-516.19%
-0.29
Basic Average Shares
10.45
-45.24%
19.09
Diluted Average Shares
10.45
-45.24%
19.09
Diluted NI Availto Com Stockholders
-18.38
-237.10%
-5.45
Line Item Trend 2022-12-31 2021-12-31
Total Assets
3.73
-49.75%
7.42
Current Assets
3.06
-54.83%
6.78
Cash Cash Equivalents And Short Term Investments
0.45
-93.14%
6.51
Cash And Cash Equivalents
0.45
-93.14%
6.51
Receivables
0.03
-84.51%
0.22
Accounts Receivable
0.03
0.00
Other Receivables
—
0.22
Prepaid Assets
0.91
0.00
Current Deferred Assets
0.09
0.00
Restricted Cash
1.51
0.00
Other Current Assets
0.07
+47.61%
0.05
Total Non Current Assets
0.66
+4.28%
0.64
Net PPE
0.57
+2.93%
0.55
Gross PPE
1.07
+11.52%
0.96
Accumulated Depreciation
-0.50
-23.33%
-0.40
Properties
0.00
0.00
Machinery Furniture Equipment
0.03
+47.97%
0.02
Construction In Progress
0.09
0.00
Other Properties
0.94
+2.18%
0.92
Leases
0.01
-47.64%
0.02
Non Current Prepaid Assets
0.04
+34.16%
0.03
Other Non Current Assets
0.05
+0.00%
0.05
Total Liabilities Net Minority Interest
9.97
-54.88%
22.10
Current Liabilities
5.06
+384.04%
1.05
Payables And Accrued Expenses
1.76
+210.94%
0.57
Payables
1.46
+249.75%
0.42
Accounts Payable
1.46
+249.75%
0.42
Current Accrued Expenses
0.30
+102.84%
0.15
Pensionand Other Post Retirement Benefit Plans Current
0.77
+119.80%
0.35
Current Debt And Capital Lease Obligation
0.20
+63.87%
0.12
Current Debt
0.46
—
Other Current Borrowings
0.46
—
Current Capital Lease Obligation
0.20
+63.87%
0.12
Current Deferred Liabilities
0.14
0.00
Current Deferred Revenue
0.14
0.00
Other Current Liabilities
2.19
+27538.56%
0.01
Total Non Current Liabilities Net Minority Interest
4.92
-76.66%
21.06
Long Term Debt And Capital Lease Obligation
0.12
-40.30%
0.20
Long Term Capital Lease Obligation
0.12
-40.30%
0.20
Preferred Securities Outside Stock Equity
4.52
-78.34%
20.86
Stockholders Equity
-6.25
+57.46%
-14.69
Common Stock Equity
-6.25
+57.46%
-14.69
Capital Stock
0.00
+5290.32%
0.00
Common Stock
0.00
+5290.32%
0.00
Share Issued
16.71
-12.46%
19.09
Ordinary Shares Number
16.71
-12.46%
19.09
Additional Paid In Capital
28.66
+1194.54%
2.21
Retained Earnings
-34.90
-106.53%
-16.90
Total Equity Gross Minority Interest
-6.25
+57.46%
-14.69
Total Capitalization
-6.25
+57.46%
-14.69
Working Capital
-2.00
-134.79%
5.74
Invested Capital
-6.25
+57.46%
-14.69
Total Debt
0.32
-1.11%
0.32
Net Debt
0.01
—
Capital Lease Obligations
0.32
-1.11%
0.32
Net Tangible Assets
-6.25
+57.46%
-14.69
Tangible Book Value
-6.25
+57.46%
-14.69
Derivative Product Liabilities
0.28
0.00
Duefrom Related Parties Current
0.00
-100.00%
0.00
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
-9.77
-160.03%
-3.76
Cash Flow From Continuing Operating Activities
-9.77
-160.03%
-3.76
Net Income From Continuing Operations
-18.00
-230.24%
-5.45
Depreciation Amortization Depletion
0.09
+9.07%
0.09
Depreciation
0.09
+9.07%
0.09
Depreciation And Amortization
0.09
+9.07%
0.09
Other Non Cash Items
7.22
+8990.79%
0.08
Stock Based Compensation
0.38
-66.29%
1.11
Operating Gains Losses
-2.01
-1150.95%
-0.16
Gain Loss On Investment Securities
-2.01
—
Gain Loss On Sale Of PPE
—
0.00
Change In Working Capital
2.55
+344.35%
0.57
Change In Receivables
-0.03
-129.60%
0.11
Changes In Account Receivables
-0.03
-131.24%
0.11
Change In Prepaid Assets
0.79
+441.69%
-0.23
Change In Payables And Accrued Expense
1.65
+129.73%
0.72
Change In Accrued Expense
0.79
+97.39%
0.40
Change In Payable
0.86
+170.23%
0.32
Change In Account Payable
0.86
+170.23%
0.32
Change In Other Working Capital
0.14
+598.39%
-0.03
Investing Cash Flow
-0.03
+79.86%
-0.14
Cash Flow From Continuing Investing Activities
-0.03
+79.86%
-0.14
Net PPE Purchase And Sale
-0.03
+79.86%
-0.14
Purchase Of PPE
-0.03
+79.86%
-0.14
Capital Expenditure
-0.03
+79.86%
-0.14
Financing Cash Flow
5.24
-49.00%
10.28
Cash Flow From Continuing Financing Activities
5.24
-49.00%
10.28
Net Issuance Payments Of Debt
0.00
-100.00%
0.75
Issuance Of Debt
0.00
-100.00%
0.75
Long Term Debt Issuance
0.00
-100.00%
0.75
Net Long Term Debt Issuance
0.00
-100.00%
0.75
Net Common Stock Issuance
0.83
0.00
Proceeds From Stock Option Exercised
0.66
+267.03%
0.18
Net Other Financing Charges
3.75
—
Changes In Cash
-4.56
-171.44%
6.38
Beginning Cash Position
6.56
+3535.90%
0.18
End Cash Position
2.00
-69.48%
6.56
Free Cash Flow
-9.80
-151.29%
-3.90
Common Stock Issuance
0.83
0.00
Issuance Of Capital Stock
0.83
-91.13%
9.35
Net Preferred Stock Issuance
0.00
-100.00%
9.35
Preferred Stock Issuance
0.00
-100.00%
9.35
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category